Literature DB >> 11585750

Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition.

D Raucher1, A Chilkoti.   

Abstract

Elastin-like polypeptides (ELPs) composed of a VPGXG repeat undergo a reversible phase transition in aqueous solution. They are hydrophilic and soluble in aqueous solution below their transition temperature (T(t)), but they become hydrophobic and aggregate when the temperature is raised above their T(t). In this study, we examine the quantitative uptake of a fluorescence-labeled, thermally responsive ELP as a function of ELP concentration between 5 and 15 microM in solution in response to hyperthermia by three cultured cancer cell lines. Flow cytometry of fluorescein-ELP conjugates showed that hyperthermia enhanced the cellular uptake of the thermally responsive ELP in human ovarian carcinoma cells (SKOV-3) and in HeLa cells at a concentration of 10 microM or higher, but not at a concentration of 5 microM, as compared with the uptake of a thermally inactive ELP control. In FaDu cells, hyperthermia stimulated uptake of the thermally responsive ELP at all solution concentrations of ELP between 5 and 15 microM. In particular, a >2-fold greater uptake of thermally responsive ELP compared with the thermally inactive control ELP was observed for FaDu cells at a solution concentration of 15 microM in heated cells. Confocal fluorescence microscopy of tumor cells incubated with a rhodamine conjugate of the thermally responsive ELP showed that the cytoplasm was uniformly stained below the T(t). Above the T(t), fluorescent particles were observed in the cytoplasm, suggesting that these particles are aggregates of the thermally responsive polypeptide resulting from the ELP phase transition. These studies demonstrate that the endocytotic uptake of a thermally responsive ELP is significantly enhanced by the thermally triggered phase transition of the polypeptide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585750

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Morphing low-affinity ligands into high-avidity nanoparticles by thermally triggered self-assembly of a genetically encoded polymer.

Authors:  Andrew J Simnick; C Alexander Valencia; Rihe Liu; Ashutosh Chilkoti
Journal:  ACS Nano       Date:  2010-04-27       Impact factor: 15.881

2.  Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo.

Authors:  Shama Moktan; Eddie Perkins; Felix Kratz; Drazen Raucher
Journal:  Mol Cancer Ther       Date:  2012-04-24       Impact factor: 6.261

3.  Peptide-based Biopolymers in Biomedicine and Biotechnology.

Authors:  Dominic Chow; Michelle L Nunalee; Dong Woo Lim; Andrew J Simnick; Ashutosh Chilkoti
Journal:  Mater Sci Eng R Rep       Date:  2008-01       Impact factor: 36.214

4.  Doxorubicin-conjugated chimeric polypeptide nanoparticles that respond to mild hyperthermia.

Authors:  Jonathan R McDaniel; Sarah R Macewan; Mark Dewhirst; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2012-03-07       Impact factor: 9.776

5.  Leveraging growth factor induced macropinocytosis for targeted treatment of lung cancer.

Authors:  Raul Iglesias; Piyush Koria
Journal:  Med Oncol       Date:  2015-10-30       Impact factor: 3.064

6.  Intelligent biosynthetic nanobiomaterials (IBNs) for hyperthermic gene delivery.

Authors:  Tze-Haw Howard Chen; Younsoo Bae; Darin Y Furgeson
Journal:  Pharm Res       Date:  2007-08-29       Impact factor: 4.200

7.  Engineering the Architecture of Elastin-Like Polypeptides: From Unimers to Hierarchical Self-Assembly.

Authors:  Soumen Saha; Samagya Banskota; Stefan Roberts; Nadia Kirmani; Ashutosh Chilkoti
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

Review 8.  Production of self-assembling biomaterials for tissue engineering.

Authors:  Stuart Kyle; Amalia Aggeli; Eileen Ingham; Michael J McPherson
Journal:  Trends Biotechnol       Date:  2009-06-06       Impact factor: 19.536

9.  A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.

Authors:  Gene L Bidwell; Aisha N Davis; Izabela Fokt; Waldemar Priebe; Drazen Raucher
Journal:  Invest New Drugs       Date:  2007-05-05       Impact factor: 3.850

Review 10.  Temperature sensitive peptides: engineering hyperthermia-directed therapeutics.

Authors:  J Andrew Mackay; Ashutosh Chilkoti
Journal:  Int J Hyperthermia       Date:  2008-09       Impact factor: 3.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.